BeOne Medicines Ltd. (ONC)
372.50
+3.44
(+0.93%)
USD |
NASDAQ |
Oct 19, 15:33
BeOne Medicines Cash from Operations (Annual) : 1.131B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.131B |
| December 31, 2024 | -140.70M |
| December 31, 2023 | -1.157B |
| December 31, 2022 | -1.497B |
| December 31, 2021 | -1.300B |
| December 31, 2020 | -1.283B |
| December 31, 2019 | -750.27M |
| Date | Value |
|---|---|
| December 31, 2018 | -547.72M |
| December 31, 2017 | 12.75M |
| December 31, 2016 | -89.51M |
| December 31, 2015 | -39.84M |
| December 31, 2014 | -8.694M |
| December 31, 2013 | 4.073M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Basilea Pharmaceutica AG | 74.76M |
| Santhera Pharmaceuticals Holding AG | -41.86M |
| AC Immune SA | -83.40M |
| CRISPR Therapeutics AG | -345.01M |
| Idorsia Ltd. | -203.32M |